HTA Evidence in Rare Diseases: Just Rare or Also Special? [PDF]
Basu A +3 more
europepmc +1 more source
TSP4 is upregulated in human and experimental AAA. TSP4 knockdown accelerated AAA formation and exacerbated both vascular inflammation and remodelling, emphasizing that TSP4 upregulation may represent a protective response against AAA. Our findings suggest that preserving TSP4 could be a useful strategy in the clinical management of AAA.
Laia Blanco‐Casoliva +10 more
wiley +1 more source
How to alleviate the shortage: a scoping review of prevention and management of global drug shortages. [PDF]
Yi Q +12 more
europepmc +1 more source
From Precision to Personalized: Catalyzing AI‐Enabled Innovation in Drug Development
ABSTRACT In 2015, President Obama announced the Precision Medicine Initiative in his nationally televised State of the Union address. The vision was bold: to enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward the development of individualized care.
Adarsh Subbaswamy +5 more
wiley +1 more source
Orphan drug propranolol for infantile hemangioma: ten-year real-world safety data from the FAERS database. [PDF]
Li X, Zhao X, Yang C, Chen A.
europepmc +1 more source
Strategic Drivers Behind Early Withdrawal of Orphan Designations in the EU: A Retrospective Analysis (2000-2024). [PDF]
Bouwman L, Castanheira M, Siotis G.
europepmc +1 more source
Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies. [PDF]
Afonso S +6 more
europepmc +1 more source
The Simultaneous Prevention of Multiple Diseases: A "One Ring to Rule Them All" Framework for Redox-Driven Health and Longevity. [PDF]
Silverstein HR +7 more
europepmc +1 more source
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders. [PDF]
Li F, Chen Q, Dai Y, Lu L.
europepmc +1 more source

